BUB1B and gynecological malignant tumors

doi:10.16352/j.issn.1001-6325.2024.12.1717

Abstract

Abstract: The BUB1 mitotic checkpoint serine/threonine kinase B (BUB1B) maintains a high fidelity of mitotic chromosome segregation by preventing the initiation of anaphase without the attachment of one or more kinetochore to the spindle, and plays a major role in both signal transduction and the stable attachment of kinetochore to microtubules. The dysregulated expression of BUB1B may affect the occurrence of mitosis-induced aneuploidy, chromosome instability and abnormal cell biological function, leading to cell malignant transformation. This review summarizes the role of BUB1B in the occurrence and development of gynecological malignant tumors.

Key words: the BUB1 mitotic checkpoint serine/threonine kinase B(BUB1B), gynecological malignant tumors, mitosis

CLC Number:

HOU Yiying, WEI Fang. BUB1B and gynecological malignant tumors[J]. Basic & Clinical Medicine, 2024, 44(12): 1717-1721.

References

[1]Zheng S, Guerrero-Haughton E, Foijer F. Chromosomal instability-driven cancer progression: interplay with the tumour microenvironment and therapeutic strategies[J]. Cells, 2023, 12: 2712.doi:10.3390/cells12232712.
[2]Lara-Gonzalez P, Pines J, Desai A. Spindle assembly checkpoint activation and silencing at kinetochores[J]. Semin Cell Dev Biol, 2021, 117: 86-98.
[3]Bloom CR, North BJ. Physiological relevance of post-translational regulation of the spindle assembly checkpoint protein BubR1[J]. Cell Biosci, 2021, 11: 76.doi: 10.1186/s13578-021-00589-2.
[4]Li X, Wang W, Ding X. Pan-cancer investigation of psoriasis-related BUB1B gene: genetical alteration and oncogenic immunology[J]. Sci Rep, 2023, 13: 6058.doi: 10.1038/s41598-023-33174-3.
[5]Terradas M, Capellá G, Valle L. Dominantly inherited hereditary nonpolyposis colorectal cancer not caused by MMR Genes[J]. J Clin Med, 2020, 9: 1954.doi: 10.3390/jcm9061954.
[6]Chung KS, Choi HE, Shin JS, et al. 6,7-Dimethoxy-3-(3-methoxyphenyl)isoquinolin-1-amine induces mitotic arrest and apoptotic cell death through the activation of spindle assembly checkpoint in human cervical cancer cells[J]. Carcinogenesis, 2013, 34: 1852-1860.
[7]Fu X, Chen G, Cai ZD, et al. Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer[J]. Onco Targets Ther, 2016, 9: 2211-2220.
[8]Komura K, Inamoto T, Tsujino T, et al. Increased BUB1B/BUBR1 expression contributes to aberrant DNA repair activity leading to resistance to DNA-damaging agents[J]. Oncogene, 2021, 40: 6210-6222.
[9]Fischer ES, Yu CWH, Bellini D, et al. Molecular mechanism of Mad1 kinetochore targeting by phosphorylated Bub1[J]. EMBO Rep, 2021, 22: e52242.doi: 10.15252/embr.202052242.
[10]Pan F, Chocarro S, Ramos M, et al. FOXM1 is critical for the fitness recovery of chromosomally unstable cells[J]. Cell Death Dis, 2023, 14: 430.doi: 10.1038/s41419-023-05946-2.
[11]Huang K, Zhang Y, Gong H, et al. Inferring evolutionary trajectories from cross-sectional transcriptomic data to mirror lung adenocarcinoma progression[J]. PLoS Comput Biol, 2023, 19: e1011122.doi: 10.1371/journal.pcbi.1011122.
[12]Guichard P, Laporte MH, Hamel V. The centriolar tubulin code[J]. Semin Cell Dev Biol, 2023, 137: 16-25.
[13]Chen Z, Liu X, Kawakami M, et al. CDK2 inhibition disorders centrosome stoichiometry and alters cellular outcomes in aneuploid cancer cells[J]. Cancer Biol Ther, 2023, 24: 2279241.doi:10.1080/15384047.2023.2279241.
[14]Sung H, Ferlay J, Siegel R L, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71: 209-249.
[15]Zhang Q, Wang Y, Xue F. ASPM, CDC20, DLGAP5, BUB1B, CDCA8, and NCAPG may serve as diagnostic and prognostic biomarkers in endometrial carcinoma[J]. Genet Res (Camb), 2022, 2022: 3217248.doi: 10.1155/2022/3217248.
[16]Chen Q, Ke H, Luo X, et al. Rare deleterious BUB1B variants induce premature ovarian insufficiency and early menopause[J]. Hum Mol Genet, 2020, 29: 2698-2707.
[17]Liu J, Liu L, Antwi PA, et al. Identification and validation of the diagnostic characteristic genes of ovarian cancer by bioinformatics and machine learning[J]. Front Genet, 2022, 13: 858466.doi:10.3389/fgene.2022.858466.
[18]蒋郁竹, 娄阁. 基于数据挖掘分析KIF14与SSK1在卵巢癌组织中的表达及临床意义[J]. 现代肿瘤医学, 2021, 29: 2800-2886.
[19]Lee YK, Choi E, Kim MA, et al. BubR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers[J]. Br J Cancer, 2009, 101: 504-510.
[20]Mcgrogan B, Phelan S, Fitzpatrick P, et al. Spindle assembly checkpoint protein expression correlates with cellular proliferation and shorter time to recurrence in ovarian cancer[J]. Human Pathology, 2014, 45: 1509-1519.
[21]Tang Q, Atiq W, Mahnoor S, et al. Comprehensively analyzing the genetic alterations, and identifying key genes in ovarian cancer[J]. Oncol Res, 2023, 31: 141-156.
[22]Singh D, Vignat J, Lorenzoni V, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative[J]. Lancet Glob Health, 2022, 11: e197-e206.
[23]李俞霆, 周常慧, 任敬秦. 生信分析宫颈癌脂质代谢酶相关基因表达及功能[J]. 生物技术, 2023, 33: 331-340.
[24]Wang L, Wang J, Jin Y, et al. Downregulation of Mad2 and BubR1 increase the malignant potential and nocoda-zole resistance by compromising spindle assembly checkpoint signaling pathway in cervical carcinogenesis[J]. J Obstet Gynaecol Res, 2019, 45: 2407-2418.
[25]谢芹. 硫利达嗪抑制宫颈癌SiHa细胞增殖及其机制研究[D]. 昆明:昆明医科大学, 2022:34-40.